- Barts Revascularisation Registry — Recruiting • Cardiology / Cardiovascular • NCT05255705.
- What is being tested: The registry evaluates minimally invasive interventional techniques for treating coronary artery disease, tracking real-world outcomes and safety data across different revascularisation approaches in contemporary practice.
- Patient eligibility overview: The registry includes patients with coronary artery disease undergoing revascularisation procedures at Barts, encompassing a broad spectrum of disease severity and patient characteristics to reflect actual clinical populations.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care…
- : * Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. * No children will be included in this study. * Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team. * Both male and female patients ≥16 years of age will be included * All patients will have had an angiogram at BHC. * Any patient who has undergone revascularisation.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.